Express Scripts Holding Company (NASDAQ:ESRX) CEO Timothy C. Wentworth acquired 8,000 shares of the company’s stock in a transaction dated Tuesday, October 31st. The stock was acquired at an average cost of $61.13 per share, with a total value of $489,040.00. Following the transaction, the chief executive officer now directly owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Express Scripts Holding Company (ESRX) traded down 0.10% on Tuesday, reaching $61.29. 3,511,897 shares of the company’s stock were exchanged. The stock has a market capitalization of $35.40 billion, a PE ratio of 10.64 and a beta of 0.88. Express Scripts Holding Company has a 12 month low of $55.80 and a 12 month high of $77.50. The firm has a 50 day moving average of $61.03 and a 200 day moving average of $61.84.

Express Scripts Holding (NASDAQ:ESRX) last announced its earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $1.90. Express Scripts Holding had a net margin of 3.64% and a return on equity of 25.46%. The business had revenue of $24.68 billion for the quarter, compared to analyst estimates of $25.68 billion. During the same quarter in the previous year, the firm posted $1.74 earnings per share. Express Scripts Holding’s revenue was down 2.9% compared to the same quarter last year. Equities analysts predict that Express Scripts Holding Company will post $7.00 earnings per share for the current fiscal year.

WARNING: “Timothy C. Wentworth Purchases 8,000 Shares of Express Scripts Holding Company (ESRX) Stock” was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/10/31/timothy-c-wentworth-purchases-8000-shares-of-express-scripts-holding-company-esrx-stock.html.

A number of hedge funds have recently made changes to their positions in ESRX. Waldron LP acquired a new stake in Express Scripts Holding during the first quarter worth $206,000. Aberdeen Asset Management PLC UK boosted its stake in Express Scripts Holding by 19.7% during the first quarter. Aberdeen Asset Management PLC UK now owns 484,444 shares of the company’s stock worth $31,930,000 after buying an additional 79,780 shares in the last quarter. GWM Advisors LLC boosted its stake in Express Scripts Holding by 8.7% during the first quarter. GWM Advisors LLC now owns 11,511 shares of the company’s stock worth $758,000 after buying an additional 920 shares in the last quarter. Brandes Investment Partners LP boosted its stake in Express Scripts Holding by 9.4% during the first quarter. Brandes Investment Partners LP now owns 2,392,377 shares of the company’s stock worth $157,682,000 after buying an additional 206,518 shares in the last quarter. Finally, NN Investment Partners Holdings N.V. boosted its stake in Express Scripts Holding by 15.5% during the first quarter. NN Investment Partners Holdings N.V. now owns 202,595 shares of the company’s stock worth $13,353,000 after buying an additional 27,240 shares in the last quarter. 88.55% of the stock is currently owned by institutional investors and hedge funds.

ESRX has been the subject of several recent research reports. Zacks Investment Research raised shares of Express Scripts Holding from a “hold” rating to a “buy” rating and set a $64.00 price objective for the company in a research report on Monday, October 16th. ValuEngine raised shares of Express Scripts Holding from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Jefferies Group LLC set a $72.00 price objective on shares of Express Scripts Holding and gave the stock a “buy” rating in a research report on Tuesday, August 29th. Needham & Company LLC initiated coverage on shares of Express Scripts Holding in a research report on Friday, July 21st. They issued a “hold” rating for the company. Finally, Robert W. Baird reissued a “hold” rating and issued a $56.00 price objective on shares of Express Scripts Holding in a research report on Friday, September 1st. Seven research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $69.56.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.